PENGXIANG HUANG to Mutation
This is a "connection" page, showing publications PENGXIANG HUANG has written about Mutation.
Connection Strength
0.375
-
Targeting p53-deficient chronic lymphocytic leukemia cells in vitro and in vivo by ROS-mediated mechanism. Oncotarget. 2016 Nov 01; 7(44):71378-71389.
Score: 0.193
-
Structural insights into brain thyroid hormone transport via MCT8 and OATP1C1. Cell. 2025 Oct 02; 188(20):5576-5588.e17.
Score: 0.088
-
Metabolic alterations in cancer cells and therapeutic implications. Chin J Cancer. 2011 Aug; 30(8):508-25.
Score: 0.034
-
A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome. Mol Pharmacol. 2006 Jul; 70(1):426-33.
Score: 0.023
-
Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J. 2005 Oct 05; 24(19):3482-92.
Score: 0.022
-
Cooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic tumorigenesis. PLoS One. 2014; 9(7):e101452.
Score: 0.010
-
The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002 Oct 04; 111(1):41-50.
Score: 0.005